<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35062705</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>30</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Retrospective Analysis of Six Years of Acute Flaccid Paralysis Surveillance and Polio Vaccine Coverage Reported by Italy, Serbia, Bosnia and Herzegovina, Montenegro, Bulgaria, Kosovo, Albania, North Macedonia, Malta, and Greece.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">44</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines10010044</ELocationID><Abstract><AbstractText>Here we analyzed six years of acute flaccid paralysis (AFP) surveillance, from 2015 to 2020, of 10 countries linked to the WHO Regional Reference Laboratory, at the Istituto Superiore di Sanit&#xe0;, Italy. The analysis also comprises the polio vaccine coverage available (2015-2019) and enterovirus (EV) identification and typing data. Centralized Information System for Infectious Diseases and Laboratory Data Management System databases were used to obtain data on AFP indicators and laboratory performance and countries' vaccine coverage from 2015 to 2019. EV isolation, identification, and typing were performed by each country according to WHO protocols. Overall, a general AFP underreporting was observed. Non-Polio Enterovirus (NPEV) typing showed a high heterogeneity: over the years, several genotypes of coxsackievirus and echovirus have been identified. The polio vaccine coverage, for the data available, differs among countries. This evaluation allows for the collection, for the first time, of data from the countries of the Balkan area regarding AFP surveillance and polio vaccine coverage. The need, for some countries, to enhance the surveillance systems and to promote the polio vaccine uptake, in order to maintain the polio-free status, is evident.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fontana</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0668-4514</Identifier><AffiliationInfo><Affiliation>Department of Infectious Disease, Istituto Superiore di Sanit&#xe0;, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buttinelli</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-1009-1447</Identifier><AffiliationInfo><Affiliation>Department of Infectious Disease, Istituto Superiore di Sanit&#xe0;, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiore</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease, Istituto Superiore di Sanit&#xe0;, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amato</LastName><ForeName>Concetta</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease, Istituto Superiore di Sanit&#xe0;, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pataracchia</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease, Istituto Superiore di Sanit&#xe0;, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kota</LastName><ForeName>Majlinda</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, Department of Control of Infectious Diseases, Institute of Public Health, 1001 Tirana, Albania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>A&#x107;imovi&#x107;</LastName><ForeName>Jela</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Public Health Institute of the Republic of Srpska, 78000 Banja Luka, Bosnia and Herzegovina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bla&#x17e;evi&#x107;</LastName><ForeName>Mia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Public Health of Federation Bosnia and Herzegovina, 71000 Sarajevo, Bosnia and Herzegovina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mulaomerovi&#x107;</LastName><ForeName>Mirsada</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Public Health of Federation Bosnia and Herzegovina, 71000 Sarajevo, Bosnia and Herzegovina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nikolaeva-Glomb</LastName><ForeName>Lubomira</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Virology, National Centre of Infectious and Parasitic Diseases, 1504 Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mentis</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Poliovirus/Enterovirus Reference Laboratory, Diagnostic Department, Hellenic Pasteur Institute, 11521 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voulgari-Kokota</LastName><ForeName>Androniki</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Poliovirus/Enterovirus Reference Laboratory, Diagnostic Department, Hellenic Pasteur Institute, 11521 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gashi</LastName><ForeName>Luljeta</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, National Institute of Public Health, 10000 Pristina, Kosovo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ka&#xe7;aniku-Gunga</LastName><ForeName>Pranvera</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, National Institute of Public Health, 10000 Pristina, Kosovo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbara</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pathology, Mater Dei Hospital, MSD2090 Msida, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melillo</LastName><ForeName>Jackie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department for Health Regulation, Health Promotion and Disease Prevention, MSD2090 Msida, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Protic</LastName><ForeName>Jelena</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-8024-1204</Identifier><AffiliationInfo><Affiliation>National Reference Laboratory for ARBO Viruses and Hemorrhagic Fever, Institute of Virology, Vaccines and Sera "Torlak", 11152 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filipovi&#x107;-Vignjevic</LastName><ForeName>Svetlana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Diagnostics and Research and Development, Institute of Virology, Vaccines and Sera "Torlak", 11152 Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Connor</LastName><ForeName>Patrick M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Global Immunization Division US Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Alberto</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Prevention of Communicable Diseases and International Prophylaxis, Directorate General of Health Prevention, Ministry of Health, 00144 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orioli</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-4767-3558</Identifier><AffiliationInfo><Affiliation>Prevention of Communicable Diseases and International Prophylaxis, Directorate General of Health Prevention, Ministry of Health, 00144 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siddu</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Prevention of Communicable Diseases and International Prophylaxis, Directorate General of Health Prevention, Ministry of Health, 00144 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saxentoff</LastName><ForeName>Eugene</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Health Emergencies and Communicable Diseases (DEC), Regional Office for Europe World Health Organization, DK-2100 Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stefanelli</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease, Istituto Superiore di Sanit&#xe0;, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant><Grant><GrantID>Full providing of laboratory support for surveillance of polioviruses in Acute Flaccid Paralysis Cases and in the Environment from specified European Countries</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant><Grant><GrantID>CCM 4S11 Grant, "Monitoraggio della circolazione di enterovirus a supporto delle attivit&#xe0; di sorveglianza per il mantenimento dello status polio-free".</GrantID><Agency>Italian Ministry of Health</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute flaccid paralysis</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">non-polio enteroviruses</Keyword><Keyword MajorTopicYN="N">polio vaccine coverage</Keyword><Keyword MajorTopicYN="N">poliovirus</Keyword><Keyword MajorTopicYN="N">poliovirus surveillance</Keyword></KeywordList><CoiStatement>The authors declare that there are no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>22</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35062705</ArticleId><ArticleId IdType="pmc">PMC8779529</ArticleId><ArticleId IdType="doi">10.3390/vaccines10010044</ArticleId><ArticleId IdType="pii">vaccines10010044</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tapparel C., Siegrist F., Petty T.J., Kaiser L. Picornavirus and enterovirus diversity with associated human diseases. Infect. Genet. Evol. 2013;14:282&#x2013;293. doi: 10.1016/j.meegid.2012.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2012.10.016</ArticleId><ArticleId IdType="pubmed">23201849</ArticleId></ArticleIdList></Reference><Reference><Citation>E Midgley S., Christiansen C.B., Poulsen M.W., Hansen C.H., Fischer T.K. Emergence of enterovirus D68 in Denmark, June 2014 to February 2015. Eurosurveillance. 2015;20:21105. doi: 10.2807/1560-7917.ES2015.20.17.21105.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES2015.20.17.21105</ArticleId><ArticleId IdType="pubmed">25955773</ArticleId></ArticleIdList></Reference><Reference><Citation>ECDC&#x2014;Rapid Risk Assessment Enterovirus Detections Associated with Severe Neurological Symptoms in Children and Adults in European Countries. 2016.  [(accessed on 23 December 2021)].  Available online:  https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/07-06-2016-RRA-Enterovirus%2071-Spain.pdf.</Citation></Reference><Reference><Citation>Broberg E.K., Simone B., Jansa J., The EU/EEA Member State Contributors Upsurge in echovirus 30 detections in five EU/EEA countries, April to September, 2018. Eurosurveillance. 2018;23:1800537. doi: 10.2807/1560-7917.ES.2018.23.44.1800537.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2018.23.44.1800537</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirolos A., Mark K., Shetty J., Chinchankar N., Mcdougall C., Eunson P., EV-D68 Associated AFM Study Group Outcome of paediatric acute flaccid myelitis associated with enterovirus D68: A case series. Dev. Med. Child Neurol. 2019;61:376&#x2013;380. doi: 10.1111/dmcn.14096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dmcn.14096</ArticleId><ArticleId IdType="pubmed">30417347</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K., Asturias E.J., Hixon A.M., Van Leer-Buter C., Niesters H.G.M., Tyler K.L., Abzug M.J., Dominguez S.R. Enterovirus D68 and acute flaccid myelitis evaluating the evidence for causality. Lancet Infect. Dis. 2018;18:e239&#x2013;e247. doi: 10.1016/S1473-3099(18)30094-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(18)30094-X</ArticleId><ArticleId IdType="pmc">PMC6778404</ArticleId><ArticleId IdType="pubmed">29482893</ArticleId></ArticleIdList></Reference><Reference><Citation>Teoh H.L., Mohammad S.S., Britton P.N., Kandula T., Lorentzos M.S., Booy R., Jones C.A., Rawlinson W., Ramachandran V., Rodriguez M.L., et al. Clinical characteristics and functional motor outcomes of enterovirus 71 neurological disease in children. JAMA Neurol. 2016;73:300&#x2013;307. doi: 10.1001/jamaneurol.2015.4388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2015.4388</ArticleId><ArticleId IdType="pubmed">26785318</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K., Spence-Davizon E., Osborne C., Press C., Schreiner T.L., Martin J., Messer R., Maloney J., Burakoff A., Barnes M., et al. Clinical characteristics of enterovirus A71 neurological disease during an outbreak in children in Colorado, USA, in 2018: An observational cohort study. Lancet Infect. Dis. 2020;20:230&#x2013;239. doi: 10.1016/s1473-3099(19)30632-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(19)30632-2</ArticleId><ArticleId IdType="pmc">PMC11284833</ArticleId><ArticleId IdType="pubmed">31859216</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruo Y., Nakanishi M., Suzuki Y., Kaneshi Y., Terashita Y., Narugami M., Takahashi M., Kato S., Suzuki R., Goto A., et al. Outbreak of aseptic meningitis caused by echovirus 30 in Kushiro, Japan in 2017. J. Clin. Virol. 2019;116:34&#x2013;38. doi: 10.1016/j.jcv.2019.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2019.05.001</ArticleId><ArticleId IdType="pubmed">31082730</ArticleId></ArticleIdList></Reference><Reference><Citation>Nougairede A., Bessaud M., Thiberville S.-D., Piorkowski G., Ninove L., Zandotti C., Charrel R., Guilhem N., de Lamballerie X. Widespread circulation of a new echovirus 30 variant causing aseptic meningitis and non-specific viral illness, South-East France, 2013. J. Clin. Virol. 2014;61:118&#x2013;124. doi: 10.1016/j.jcv.2014.05.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2014.05.022</ArticleId><ArticleId IdType="pubmed">24973284</ArticleId></ArticleIdList></Reference><Reference><Citation>Kew O.M., Sutter R.W., de Gourville E.M., Dowdle W.R., Pallansch M.A. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu. Rev. Microbiol. 2005;59:587&#x2013;635. doi: 10.1146/annurev.micro.58.030603.123625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.micro.58.030603.123625</ArticleId><ArticleId IdType="pubmed">16153180</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC  Global Immunization.  [(accessed on 23 December 2021)]; Available online:  https://www.cdc.gov/polio/what-we-do/index.htm.</Citation></Reference><Reference><Citation>World Health Organization . WHO-Recommended Standards for Surveillance of Selected Vaccine Preventable Diseases. World Health Organization; Geneva, Switzerland: 1999.</Citation></Reference><Reference><Citation>CDC. WHO . Enterovirus Surveillance Guidelines. Guidelines for Enterovirus Surveillance in Support of the Polio Eradication Initiative. World Health Organization; Geneva, Switzerland: 2015.</Citation></Reference><Reference><Citation>Global Commission for the Certification of Poliomyelitis Eradication  . 14th Meeting of the Global Commission for the Certification of Poliomyelitis Eradication (GCC) [Monograph on the Internet] World Health Organization; Geneva, Switzerland: 2015.  [(accessed on 10 September 2018)].  Available online:  http://polioeradication.org/wpcontent/uploads/2016/07/1Report.pdf.</Citation></Reference><Reference><Citation>Famulare M. Has Wild Poliovirus Been Eliminated from Nigeria? PLoS ONE. 2015;10:e0135765. doi: 10.1371/journal.pone.0135765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0135765</ArticleId><ArticleId IdType="pmc">PMC4552877</ArticleId><ArticleId IdType="pubmed">26317401</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu C.H., Kader M., Mahamud A., Bullard K., Jorba J., Agbor J., Safi M.M., Jafari H.S., Ehrhardt D. Progress Toward Poliomyelitis Eradication&#x2014;Pakistan, January 2018&#x2013;September 2019. MMWR. Morb. Mortal. Wkly. Rep. 2019;68:1029&#x2013;1033. doi: 10.15585/mmwr.mm6845a5.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6845a5</ArticleId><ArticleId IdType="pmc">PMC6855509</ArticleId><ArticleId IdType="pubmed">31725710</ArticleId></ArticleIdList></Reference><Reference><Citation>ECDC  . Outbreak of Circulating Vaccine-Derived Poliovirus Type 1(cVDPV1) in Ukraine. European Centre for Disease Prevention and Control; Solna, Swden: 2015.  [(accessed on 2 September 2015)].  Available online:  http://ecdc.europa.eu/en/publications/publications/poliomyelitis-ukraine-rapid-riskassessment-september-2015.pdf.</Citation></Reference><Reference><Citation>Fontana S., Buttinelli G., Fiore S., Mulaomerovic M., A&#x107;imovi&#x107; J., Amato C., Delogu R., Rezza G., Stefanelli P. Acute flaccid paralysis surveillance in Bosnia and Herzegovina: Recent isolation of two sabin like type 2 poliovirus. J. Med. Virol. 2017;89:1678&#x2013;1681. doi: 10.1002/jmv.24827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24827</ArticleId><ArticleId IdType="pubmed">28390186</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  . Polio Laboratory Manual. World Health Organization; Geneva, Switzerland: 2004.  [(accessed on 23 December 2021)].  WHO/IVB/04.10. Available online:  http://apps.who.int/iris/bitstream/10665/68762/1/WHO_IVB_04.10.pdf.</Citation></Reference><Reference><Citation>WHO  Supplement to the WHO Polio Laboratory Manual. 2014.  [(accessed on 23 December 2021)].  Available online:  https://polioeradication.org/wp-content/uploads/2017/05/NewAlgorithmForPoliovirusIsolationSupplement1.pdf.</Citation></Reference><Reference><Citation>Burns C.C., Kilpatrick D.R., Iber J.C., Chen Q., Kew O.M. Molecular Properties of Poliovirus Isolates: Nucleotide Sequence Analysis, Typing by PCR and Real-Time RT-PCR. Springer Protoc. Handb. 2016;1387:177&#x2013;212. doi: 10.1007/978-1-4939-3292-4_9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-3292-4_9</ArticleId><ArticleId IdType="pubmed">26983735</ArticleId></ArticleIdList></Reference><Reference><Citation>Kojouharova M., Zuber P.L.F., Gyurova S., Fiore L., Buttinelli G., Kunchev A., Vladimirova N., Korsun N., Filipova R., Boneva R., et al. Importation and circulation of poliovirus in Bulgaria in 2001. Bull. World Heal. Organ. 2003;81:476&#x2013;481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2572497</ArticleId><ArticleId IdType="pubmed">12973639</ArticleId></ArticleIdList></Reference><Reference><Citation>Zomahoun D.J., Burman A.L., Snider C.J., Chauvin C., Gardner T., Lickness J.S., Ahmed J.A., Diop O., Gerber S., Anand A. Impact of COVID-19 Pandemic on Global Poliovirus Surveillance. MMWR. Morb. Mortal. Wkly. Rep. 2021;69:1648&#x2013;1652. doi: 10.15585/mmwr.mm695152a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm695152a4</ArticleId><ArticleId IdType="pmc">PMC9191906</ArticleId><ArticleId IdType="pubmed">33382673</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesfaye B., Sowe A., Kisangau N., Ogange J., Ntoburi S., Nekar I., Muitherero C., Camara Y., Gathenji C., Langat D., et al. An epidemiological analysis of Acute Flaccid Paralysis (AFP) surveillance in Kenya, 2016 to 2018. BMC Infect. Dis. 2020;20:1&#x2013;11. doi: 10.1186/s12879-020-05319-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05319-6</ArticleId><ArticleId IdType="pmc">PMC7437168</ArticleId><ArticleId IdType="pubmed">32811467</ArticleId></ArticleIdList></Reference><Reference><Citation>Odoom J.K., Ntim N.A.A., Sarkodie B., Addo J., Minta-Asare K., Obodai E., Eshun M., Ahove V.V., Diamenu S., Adjabeng M., et al. Evaluation of AFP surveillance indicators in polio-free Ghana, 2009&#x2013;2013. BMC Public Health. 2014;14:687. doi: 10.1186/1471-2458-14-687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-14-687</ArticleId><ArticleId IdType="pmc">PMC4094438</ArticleId><ArticleId IdType="pubmed">24996415</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamisu A.W., Johnson T.M., Craig K., Mkanda P., Banda R., Tegegne S.G., Oyetunji A., Ningi N., Mohammed S.M., Adamu M.I., et al. Strategies for improving polio surveillance performance in the security challenged Nigerian States of Adamawa, Borno, and Yobe during 2009&#x2013;2014. J. Infect. Dis. 2016;213((Suppl. S3)):S136&#x2013;S139. doi: 10.1093/infdis/jiv530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiv530</ArticleId><ArticleId IdType="pmc">PMC4818552</ArticleId><ArticleId IdType="pubmed">26655842</ArticleId></ArticleIdList></Reference><Reference><Citation>Chard A.N., Datta S.D., Tallis G., Burns C.C., Wassilak S.G., Vertefeuille J.F., Zaffran M. Progress Toward Polio Eradication&#x2014;Worldwide, January 2018&#x2013;March 2020. MMWR. Morb. Mortal. Wkly. Rep. 2020;69:784&#x2013;789. doi: 10.15585/mmwr.mm6925a4.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6925a4</ArticleId><ArticleId IdType="pmc">PMC7316320</ArticleId><ArticleId IdType="pubmed">32584798</ArticleId></ArticleIdList></Reference><Reference><Citation>Snider C.J., Diop O.M., Burns C.C., Tangermann R.H., Wassilak S.G.F. Surveillance systems to track progress toward polio eradication&#x2014;worldwide, 2014&#x2013;2015. Morb. Mortal. Wkly. Rep. 2016;65:346&#x2013;351. doi: 10.15585/mmwr.mm6513a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6513a3</ArticleId><ArticleId IdType="pubmed">27054558</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Regional Office for Europe  32nd Meeting of the European Regional Commission for Certification of Poliomyelitis Eradication. Report 2018.  [(accessed on 24 October 2019)].  Available online:  http://www.euro.who.int/en/health-topics/communicable-diseases/poliomyelitis/publications/2018/32nd-meeting-of-the-european-regional-commission-for-certification-of-poliomyelitis-eradication-rcc-report-2018.</Citation></Reference><Reference><Citation>Gianfredi V., D&#x2019;Ancona F., Maraglino F., Cenci C., Iannazzo S. Polio and measles: Reasons of missed vaccination in Italy, 2015-2017. Ann. Ig. Med. Prev. Comunita. 2019;31:191&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">31069364</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowdle W., Van Der Avoort H., De Gourville E., Delpeyroux F., Desphande J., Hovi T., Martin J., Pallansch M., Kew O., Wolff C. Containment of Polioviruses After Eradication and OPV Cessation: Characterizing Risks to Improve Management. Risk Anal. 2006;26:1449&#x2013;1469. doi: 10.1111/j.1539-6924.2006.00844.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1539-6924.2006.00844.x</ArticleId><ArticleId IdType="pubmed">17184392</ArticleId></ArticleIdList></Reference><Reference><Citation>Manor Y., Handsher R., Halmut T., Neuman M., Bobrov A., Rudich H., Vonsover A., Shulman L., Kew O., Mendelson E. Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian authority. J. Clin. Microbiol. 1999;37:1670&#x2013;1675. doi: 10.1128/JCM.37.6.1670-1675.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.37.6.1670-1675.1999</ArticleId><ArticleId IdType="pmc">PMC84919</ArticleId><ArticleId IdType="pubmed">10325305</ArticleId></ArticleIdList></Reference><Reference><Citation>Shulman L.M., Gavrilin E., Jorba J., Martin J., Burns C.C., Manor Y., Moran-Gilad J., Sofer D., Hindiyeh M.Y., Gamzu R., et al. Molecular epidemiology of silent introduction and sustained transmission of wild poliovirus type 1, Israel, 2013. Eurosurveillance. 2014;19:20709. doi: 10.2807/1560-7917.ES2014.19.7.20709.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES2014.19.7.20709</ArticleId><ArticleId IdType="pubmed">24576471</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomqvist S., El Bassioni L., El Maamoon Nasr E.M., Paananen A., Kaijalainen S., Asghar H., de Gourville E., Roivainen M. Detection of Imported Wild Polioviruses and of Vaccine-Derived Polioviruses by Environmental Surveillance in Egypt. Appl. Environ. Microbiol. 2012;78:5406&#x2013;5409. doi: 10.1128/AEM.00491-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.00491-12</ArticleId><ArticleId IdType="pmc">PMC3416427</ArticleId><ArticleId IdType="pubmed">22582070</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomqvist S., El Bassioni L., El Maamoon Nasr E.M., Paananen A., Kaijalainen S., Asghar H., de Gourville E., Roivainen M. Highly divergent neurovirulent vaccine-derived polioviruses of all three serotypes are recurrently detected in Finnish sewage. Euro Surveill Bull. Eur. Mal. Transm. Eur. Commun. Dis. Bull. 2010;15:19566.</Citation><ArticleIdList><ArticleId IdType="pubmed">20483108</ArticleId></ArticleIdList></Reference><Reference><Citation>Platt L.R., Est&#xed;variz C.F., Sutter R.W. Vaccine-associated paralytic poliomyelitis: A review of the epidemiology and estimation of the global burden. J. Infect. Dis. 2014;210:S380&#x2013;S389. doi: 10.1093/infdis/jiu184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu184</ArticleId><ArticleId IdType="pmc">PMC10424844</ArticleId><ArticleId IdType="pubmed">25316859</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns C.C., Diop O.M., Sutter R.W., Kew O.M. Vaccine-derived polioviruses. J. Infect. Dis. 2014;210:S283&#x2013;S293. doi: 10.1093/infdis/jiu295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu295</ArticleId><ArticleId IdType="pubmed">25316847</ArticleId></ArticleIdList></Reference><Reference><Citation>Delogu R., Battistone A., Buttinelli G., Fiore S., Fontana S., Amato C., Cristiano K., Gamper S., Simeoni J., Frate R., et al. Poliovirus and Other Enteroviruses from Environmental Surveillance in Italy, 2009&#x2013;2015. Food Environ. Virol. 2018;10:333&#x2013;342. doi: 10.1007/s12560-018-9350-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12560-018-9350-8</ArticleId><ArticleId IdType="pubmed">29948963</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontana S., Fiore S., Buttinelli G., Amato C., Veronesi L., Zoni R., Triassi M., Pennino F., Giammanco G.M., De Grazia S., et al. Molecular Characterization of Coxsackievirus B5 Isolates from Sewage, Italy 2016&#x2013;2017. Food Environ. Virol. 2019;11:440&#x2013;445. doi: 10.1007/s12560-019-09395-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12560-019-09395-z</ArticleId><ArticleId IdType="pmc">PMC6848032</ArticleId><ArticleId IdType="pubmed">31346976</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>